Research

MK Chattopadhyay, Retired Senior Principal Scientist, Centre for Cellular and Molecular Biology (CSIR), talks about the urgent…

The study was a multinational randomised double-blind controlled trial of 52 weeks duration which included more than 500 patients…

Cancer cells are killed more effectively and selectively with a new approach, using a substance found in stinging nettles and…

India has already become the world capital of diabetes and heart diseases, and is set to acquire the same dubious distinction in…

By Biten Kathrani, Director R&D, Asia Pacific, Boston Scientific outlines the trends which will drive progress in the R&D…

Biocon has recently launched a biosimilar in the Indian market. Suresh Subramanian, Sr Vice President & Head Branded…

37 per cent of patients in a closely watched clinical trial who received Tecentriq, Avastin and chemotherapy reached the one-year…

The review covers combination therapy for the adjuvant treatment of patients with stage III melanoma

The ZPIV vaccine, made from inactivated Zika virus particles, was developed by US Army researchers, who in July 2016 had agreed to…

The company said it plans to price the drug at $676 per prescription, which it described as ‘at parity’ to current market-leading…